Survival after treatment for carcinoma invading bladder muscle: A Dutch populationbased study on the impact of hospital volume

BJU International

Volumn 110, Issue 2, 2012, Pages 226-232

  Goossens Laan, Catharina A ^a   Visser, Otto ^b   Hulshof, Maarten C C M ^c   Wouters, Michel W ^d,e   Bosch, J L H Ruud ^a   Coebergh, Jan Willem W ^f   Kil, Paul J M ^g  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Integraal Kankercentrum Amsterdam   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f The Netherlands   (Netherlands)

^g CPRLab   (Netherlands)

Author keywords

Bladder cancer; Cystectomy; Population based; Survival rate; Treatment; Volume

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER MUSCLE; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA; CYSTECTOMY; FEMALE; HEALTH FACILITY SIZE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; NETHERLANDS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84863449956     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10694.x     Document Type: Article

References (24)

1. Comprehensive Cancer Centres. Incidence of invasive tumours in men and women to location and year of incidence. 2011. Web site. Available at: http://www.cijfersoverkanker.nl/p=4ea5c1c8c3c8f. Accessed October 2011
2. Batterman JJ, Feller N, Hamelers- Paulus HWG, de Reijke TM, Witjes JA. Guideline Diagnostics, treatment and follow-up of the urothelial cell carcinoma of the bladder. 2008. http://www.oncoline.nl/richtlijn/item/pagina.php? richtlijn-id=617
3. CZ. Verantwoordingsbeleid blasverwijderingsoperaties. 2010. Available at: http://www.cz.nl/verantwoordingsdocument- blasverwijderingsoperatieszorgaanbieders.pdf. Accessed October 2010
4. Goossens-Laan CA, Visser O, Wouters MW et al. Variations in treatment policies and outcome for bladder cancer in the Netherlands. Eur J Surg Oncol 2010; 36 (Suppl. 1): S100-S107
5. Shabsigh A, Korets R, Vora KC et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2008; 55: 164-74
6. Fritz A. International Classification of Diseases for Oncology. Geneva: World Health Organization, 2000
7. Schouten LJ, Jager JJ, van den Brandt PA. Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel. Br J Cancer 1993; 68: 974-7 (Pubitemid 23315233)
8. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, the Netherlands. Int J Epidemiol 1993; 22: 369-76 (Pubitemid 23208931)
9. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 6th edn. New York: Wiley-Liss, 2002
10. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933-42
11. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004; 23: 51-64 (Pubitemid 38072106)
12. Hayter CR, Paszat LF, Groome PA, Schulze K, Mackillop WJ. The Management and outcome of bladder carcinoma in Ontario, 1982-1994. Cancer 2000; 89: 142-51 (Pubitemid 30451284)
13. Hayne D, Arya M, Quinn MJ, Babb PJ, Beacock CJ, Patel HR. Current trends in bladder cancer in England and Wales. J Urol 2004; 172: 1051-5 (Pubitemid 39096461)
14. Visser O, Nieuwenhuijzen JA, Horenblas S. Local recurrence after cystectomy and survival of patients with bladder cancer: a population based study in greater Amsterdam. J Urol 2005; 174: 97-102 (Pubitemid 40825682)
15. Gore JL, Litwin MS, Lai J et al. Use of radical cystectomy for patients with invasive bladder cancer. JNCI 2010; 105: 802-11
16. Van der Werf-Messing BH, van Putten WL. Carcinoma of the urinary bladder category T2, 3NXM0 treated by 40 Gy external irradiation followed by Cesium137 implant at reduced dose (50%). Int J Radiat Oncol Biol Phys 1989; 16: 369-71
17. Siesling S, Visser O, Luth TK et al. [ Adult cancer patients are surviving longer in the Netherlands: 5-year survival rate increased by 12% between the periods 1989-1993 and 2004-2008 ]. Ned Tijdschr Geneeskd 2011; 155: A3169
18. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005; 55: 231-40 (Pubitemid 41222320)
19. Chamie K, Hu B, Vere White RW, Ellison LM. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int 2008; 102: 284-90 (Pubitemid 352019198)
20. Clark PE, Stein JP, Groshen SG et al. Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer 2005; 104: 36-43 (Pubitemid 40847750)
21. Farnham SB, Cookson MS, Alberts G, Smith JA Jr, Chang SS. Benefit of radical cystectomy in the elderly patient with significant co-morbidities. Urol Oncol 2004; 22: 178-81 (Pubitemid 38950621)
22. Goossens-Laan CA, Gooiker GA, van Gijn W et al. A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate. Eur Urol 2011; 59: 775-83
23. Goossens-Laan CA, Kil PJ, Roukema JA, Bosch JL, De Vries J. Quality of care indicators for muscle-invasive bladder cancer. Urol Int 2011; 86: 11-8
24. Lughezzani G, Sun M, Shariat S et al. A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer. Cancer 2011; 117: 103-9